Tassos Gianakakos | CEO |
Marc Semigran | CMO |
Jake Bauer | SVP, Finance & Corporate Development |
Ian Somaiya | BMO Capital |
Vamil Divan | Credit Suisse |
Jim Birchenough | Wells Fargo Securities |
Ritu Baral | Cowen |
Good morning, and thank you for joining us today for MyoKardia Financial Results and Corporate Update Call for the Third Quarter of 2017. Leading today's call is MyoKardia's CEO, Tassos Gianakakos. Tassos is joined today by Dr. Marc Semigran, MyoKardia's Chief Medical Officer, and Jake Bauer, Senior Vice President of Finance and Corporate Development. A press release of the company's third quarter 2017 financial results and progress.